Careers

Home ¬Ľ Careers

Open Positions

Independent Rater
Norway

MAPS Europe B.V., a trial sponsor, aims to obtain approval for the prescription use of 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy in patients with posttraumatic stress disorder (PTSD).